RT Dr_MBaljevic "Mod-to-severe CRI not requiring HD has no influence on #Pomalidomide clearance or plasma exposure. It should be administered post-HD on HD days to avoid enhanced clarence https://t.co/Q1Dujeidhu"

Mod-to-severe CRI not requiring HD has no influence on #Pomalidomide clearance or plasma exposure. It should be administered post-HD on HD days to avoid enhanced clarence https://t.co/ngvzned2mZ

Population pharmacokinetics of #Pomalyst in patients with relapsed or refractory multiple #myeloma with various degrees of impaired renal function finds no influence on drug clearance or plasma exposure: https://t.co/0dXxNte2DQ. https://t.co/Zj2rhXUVvk